https://scholars.lib.ntu.edu.tw/handle/123456789/580446
標題: | Treatment of recurrent Kaposi's sarcoma of an AIDS patient with weekly paclitaxel | 作者: | CHIH-HUNG HSU Chen M.-Y. ANN-LII CHENG |
公開日期: | 2000 | 卷: | 20 | 期: | 2 B | 起(迄)頁: | 1159-1161 | 來源出版物: | Anticancer Research | 摘要: | Paclitaxel was recently recognized as an active chemotherapeutic agent for acquired immunodeficiency syndrome (AIDS)-associated Kaposi's sarcoma (KS). However, the best way to administer paclitaxel in AIDS-KS patients remains unknown. Herein, we reported an AIDS-associated KS patient whose disease progressed on the first-line chemotherapy with doxorubicin and bleomycin, but later responded well to weekly 1-hour infusion of 70 mg/m2 paclitaxel. It is particular noteworthy that this weekly dosing schedule resulted in almost negligible toxicities. The authors suggested a prospective study of weekly paclitacel for AIDS-KS should be started as soon as possible. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034054140&partnerID=40&md5=4b8dc32ba9cdd8adb0d396783cfd6d10 https://scholars.lib.ntu.edu.tw/handle/123456789/580446 |
ISSN: | 0250-7005 | SDG/關鍵字: | bleomycin; doxorubicin; etoposide; paclitaxel; vincristine; acquired immune deficiency syndrome; adult; article; case report; human; Kaposi sarcoma; male; priority journal; side effect; Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Agents, Phytogenic; Dexamethasone; Diphenhydramine; Drug Administration Schedule; Humans; Infusions, Intravenous; Male; Paclitaxel; Ranitidine; Sarcoma, Kaposi |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。